Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yasuda

Showing results (691-700 of 703) with videos related to

Pageof 71
Sort By:
The Journal of Experimental Medicine|January 19, 2000
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionK Kobayashi, N Takahashi, E Jimi, et al.
Diabetes/Metabolism Research and Reviews|March 2, 2005
A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in IndonesiaC W Danawati, M Nagata, H Moriyama, et al.
Die Pharmazie|June 3, 2021
Effect of renin-angiotensin system inhibitors on pemetrexed plus platinum-induced hematological toxicities: a multicenter retrospective study using three propensity score analysesT Arami, H Kawazoe, R Uozumi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLH Yasuda, N Shima, N Nakagawa, et al.
Journal of Human Hypertension|May 26, 2007
Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertensionH Yasuda, K Kamide, S Takiuchi, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2002
Synthesis and in vitro antifungal activities of novel triazole antifungal agent CS-758T Konosu, S Oida, Y Nakamura, et al.
Biochemical and Biophysical Research Communications|July 2, 1998
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerinA Mizuno, N Amizuka, K Irie, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenemT Fukuoka, S Ohya, Y Utsui, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 3, 2019
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodiesT Sakakida, T Ishikawa, Y Chihara, et al.
Neurology|April 27, 2005
Clinical and electrophysiologic correlates of IVIg responsiveness in CIDPM Iijima, M Yamamoto, M Hirayama, et al.
Pageof 71

Showing results (691-700 of 703) with videos related to

Sort By:
Pageof 71
The Journal of Experimental Medicine|January 19, 2000
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionK Kobayashi, N Takahashi, E Jimi, et al.
Diabetes/Metabolism Research and Reviews|March 2, 2005
A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in IndonesiaC W Danawati, M Nagata, H Moriyama, et al.
Die Pharmazie|June 3, 2021
Effect of renin-angiotensin system inhibitors on pemetrexed plus platinum-induced hematological toxicities: a multicenter retrospective study using three propensity score analysesT Arami, H Kawazoe, R Uozumi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLH Yasuda, N Shima, N Nakagawa, et al.
Journal of Human Hypertension|May 26, 2007
Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertensionH Yasuda, K Kamide, S Takiuchi, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2002
Synthesis and in vitro antifungal activities of novel triazole antifungal agent CS-758T Konosu, S Oida, Y Nakamura, et al.
Biochemical and Biophysical Research Communications|July 2, 1998
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerinA Mizuno, N Amizuka, K Irie, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenemT Fukuoka, S Ohya, Y Utsui, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 3, 2019
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodiesT Sakakida, T Ishikawa, Y Chihara, et al.
Neurology|April 27, 2005
Clinical and electrophysiologic correlates of IVIg responsiveness in CIDPM Iijima, M Yamamoto, M Hirayama, et al.
Pageof 71